Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study

Authors: Michael A Rosenberg, MD, Michelle Samuel, BA, Amit Thosani, MD, Peter J Zimetbaum, MD.

Study comparing Zio patch monitor with traditional Holter to detect paroxysmal AF.

AF detected in 24.3% of patients with Zio monitor that would have been missed with traditional Holter.

Average day to diagnosis 3.7 days.

28.4% patients had change in management with Zio compared to Holter.

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.

Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study

Summary

Key Findings